Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled trial of Xilonix in metastatic colorectal cancer
RBR-3kzxsfPhase 3Recruiting
- Sponsor
- XBiotech Inc.
- Start
- Sep 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in colorectal cancer (CRC) comparing Xilonix with Placebo (2 arms). Started Sep 2015; status: recruiting.
02
Drugs
bermekimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on RBR-3kzxsf.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3kzxsf.